首页|生长激素不同用药频次对高龄患者IVF/ICSI助孕临床结局的影响

生长激素不同用药频次对高龄患者IVF/ICSI助孕临床结局的影响

扫码查看
目的 探讨重组人生长激素(growth hormone,GH)两种不同的预处理用药频次对高龄患者体外受精/卵胞浆内单精子显微注射(in vitro fertilization/intracytoplasmic sperm injection,IVF/ICSI)助孕中临床结局的影响.方法 回顾性分析广西壮族自治区妇幼保健院生殖医学中心2020年1月至2023年6月IVF/ICSI助孕的35~43岁女性,采用短效GnRH-a长方案并辅助使用GH预处理共242个周期,按照不同GH用药频次分组,A组GH 2 U,一天一次给药,共38个周期,B组GH 2 U,隔天一次给药,共204个周期,采用倾向性得分匹配(PSM),对两组患者年龄、体质量指数(BMI)、抗苗勒管激素(AMH)和基础窦卵泡数(AFC)进行1∶1匹配,匹配容积设为0.02,匹配后两组各38个周期,比较两组患者平均获卵数、可利用胚胎数、优胚数、临床妊娠率等临床指标.结果 匹配后两组的Gn天数、Gn总量差异无统计学意义(P>0.05);hCG注射日E2水平(9 089.56±5 778.61 vs.5 949.34±3 939.86)、平均获卵数(9.00±6.05 vs.5.58±3.57)、可利用胚胎数(3.68±2.62 vs.2.21±1.40)及优胚数(2.58±2.62 vs.1.50±1.37)比较,差异有统计学意义(P<0.05).两组患者新鲜周期移植妊娠率、胚胎种植率比较,差异无统计学意义(P>0.05).移植日期截至2023年12月31日,两组的取卵周期累计妊娠率(44.74%vs.18.42%)比较,差异有统计学意义(P<0.05).结论 对于高龄患者IVF/ICSI助孕中采用短效GnRH-a长方案患者,辅助使用GH 2 U qd的用药频次可增加可用胚胎数.
Effect of different frequency of growth hormone on the clinical outcome of IVF/ICSI in elderly patients
Objective To investigate the effect of two different pretreatment frequencies of recombinant human growth hormone(GH)on the clinical outcomes of in vitro fertilization/intracytoplasmic sperm injection(IVF/ICSI)in elderly patients.Methods Review of 242 cycles of IVF/ICSI assisted reproduction in women aged 35~43 from January 2020 to June 2023 at the Reproductive Medical Center of Maternal and Child Health Care of Guangxi Zhuang Autonomous Region,in which short-acting GnRH-a long protocol with GH pretreatment was used.The patients were divided into two groups based on different GH dosing frequencies:group A received 2 U qd for 38 cycles,and group B received 2 U qod for 204 cycles.Propensity score matching(PSM)was used to match patients in terms of age,body mass index(BMI),anti-Miillerian hormone(AMH),and antral follicle count(AFC)in 1∶1 ratio with a matching ratio of 0.02.After matching,each group consisted of 38 cycles,and clinical indicators such as the average number of retrieved oocytes,usable embryos,high-quality embryos,and clinical pregnancy rate were compared between the two groups.Results There were no statistically significant differences in the duration and total dose of gonadotropin(Gn)treatment between the two matched groups(P>0.05).However,there were statistically significant differences in the levels of estradiol(E2)on the day of human chorionic gonadotropin(hCG)injection(9 089.56±5 778.61 vs.5 949.34±3 939.86),the average number of retrieved oocytes(9.00±6.05 vs.5.58±3.57)and number of usable embryos(3.68±2.62 vs.2.21±1.40)and number of good-quality embryos(2.58±2.62 vs.1.50±1.37)(P<0.05).There were no statistically significant differences in fresh cycle implantation rate and embryo implantation rate between the two groups(P>0.05).December 31,2023,there was a statistically significant difference in the cumulative pregnancy rate(44.74%vs.18.42%)during the oocyte retrieval cycles between the two groups(P<0.05).Conclusion For elderly patients undergoing short acting GnRH-a long protocol in IVF/ICSI assisted pregnancy,the frequency of using GH 2 U qd as dosing frequencies can increase the number of available embryos.

advanced agegrowth hormonein vitro fertilizationnumber of usable embryos

蒙亚晴、周红、邓曦和、蔡君英、李艳娟、梁贵

展开 >

530003 广西 南宁,广西壮族自治区妇幼保健院生殖医学中心

高龄 生长激素 体外受精 可利用胚胎数

广西壮族自治区卫生健康委员会自筹经费科研课题

Z20210227

2024

中国计划生育和妇产科
中国医师协会 四川省医学情报研究所

中国计划生育和妇产科

CSTPCD
影响因子:1.116
ISSN:1674-4020
年,卷(期):2024.16(6)
  • 3